Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZB30 Phase III trial in male idiopathic hypogonadotropic hypogonadism with azoospermia
CTR20231806Phase 3Active
- Sponsor
- Jingze Biopharmaceutical
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of follitropin alfa in hypogonadotropic hypogonadism (HH), azoospermia, sponsored by Jingze Biopharmaceutical. Started Jun 2023; status: active.
02
Drugs
follitropin alfa
03
Conditions
hypogonadotropic hypogonadism (HH)azoospermia
Beyond the preview
Go deeper on CTR20231806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231806.